BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8845299)

  • 1. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
    Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of the v-Src protein tyrosine kinase.
    Fincham V; Frame M; Haefner B; Unlu M; Wyke A; Wyke J
    Cell Biol Int; 1994 May; 18(5):337-44. PubMed ID: 8049678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
    Catling AD; Wyke JA; Frame MC
    Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenesis induced by pp60v-src is not accompanied by increased expression of immediate early response genes.
    Welham MJ; Wyke JA; Lang A; Wyke AW
    Oncogene; 1990 Feb; 5(2):161-9. PubMed ID: 2108404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src tyrosine kinase mediates stimulation of Raf-1 and mitogen-activated protein kinase by the tumor promoter thapsigargin.
    Chao TS; Abe M; Hershenson MB; Gomes I; Rosner MR
    Cancer Res; 1997 Aug; 57(15):3168-73. PubMed ID: 9242445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts.
    Kortenjann M; Shaw PE
    Oncogene; 1995 Nov; 11(10):2105-12. PubMed ID: 7478530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus.
    Durkin JP; Whitfield JF
    J Cell Physiol; 1984 Aug; 120(2):135-45. PubMed ID: 6086674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. v-raf confers CSF-1 independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation.
    Büscher D; Dello Sbarba P; Hipskind RA; Rapp UR; Stanley ER; Baccarini M
    Oncogene; 1993 Dec; 8(12):3323-32. PubMed ID: 8247534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
    Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
    Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.
    Han JW; Gaut J; Burstein E; Sadowski H; Young D; Macara IG
    Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p60(v-src) and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells.
    Aouacheria A; Ory S; Schmitt JR; Rigal D; Jurdic P; Gillet G
    Oncogene; 2002 Feb; 21(8):1171-86. PubMed ID: 11850837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation.
    Bonapace IM; Addeo R; Altucci L; Cicatiello L; Bifulco M; Laezza C; Salzano S; Sica V; Bresciani F; Weisz A
    Oncogene; 1996 Feb; 12(4):753-63. PubMed ID: 8632897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of growth factor-independence and GM-CSF secretion by the v-src oncogene in murine myeloid cells does not require membrane association of pp60v-src.
    Ostermeyer AG; Anderson SM
    Exp Hematol; 1996 Feb; 24(2):176-84. PubMed ID: 8641339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the mitogen-activated protein kinase cascade in response to the temperature inducible expression of v-mos kinase.
    Topol LZ; Blair DG
    Cell Growth Differ; 1995 Sep; 6(9):1119-27. PubMed ID: 8519689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role for c-jun in cell cycle progression through late G1 and S.
    Carter R; Cosenza SC; Pena A; Lipson K; Soprano DR; Soprano KJ
    Oncogene; 1991 Feb; 6(2):229-35. PubMed ID: 1900357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupling of the pathways which link MAP kinase to c-fos transcription and AP-1 in response to growth stimuli.
    Wyke AW; Lang A; Frame MC
    Cell Signal; 1996 Feb; 8(2):131-9. PubMed ID: 8730515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.